4//SEC Filing
ACHILLION PHARMACEUTICALS INC 4
Accession 0001209191-16-093101
CIK 0001070336operating
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 4:10 PM ET
Size
5.5 KB
Accession
0001209191-16-093101
Insider Transaction Report
Form 4
Apelian David
EVP and Chief Medical Officer
Transactions
- Award
Employee Stock Option
2016-01-20+118,000→ 118,000 totalExercise: $7.61Exp: 2026-01-20→ Common Stock (118,000 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date.
Documents
Issuer
ACHILLION PHARMACEUTICALS INC
CIK 0001070336
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070336
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 4:10 PM ET
- Size
- 5.5 KB